Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Nuformix plc 1RT Apr 25, 2025 0.00 0.00   
 NuGen Medical Devices Inc 79O Apr 25, 2025 0.06 +133.60   
 NUIX LTD. 3SJ Apr 25, 2025 1.33 0.00   
 Nukkleus N86 0.00 0.00   
 NuLegacy Gold Corp 7NU Apr 25, 2025 0.00 0.00   
 Nuran Wireless Inc 1RNA Apr 25, 2025 0.04 +0.51   
 NUREXONE BIOLOGIC INC. J90 Apr 25, 2025 0.43 +5.13   
 Nurminen Logistics 8I4 Apr 25, 2025 1.13 +14.14   
 Nutanix, Inc. - Class A 0NU Apr 25, 2025 59.00 +8.74   
 Nutriband Inc 9WV Apr 25, 2025 4.62 +7.94   
 Nutrien Ltd N7T Apr 25, 2025 47.40 +1.98   
 Nuveen Churchill Direct Lending O7A Apr 25, 2025 13.90 +5.30   
 Nuveen Preferred And Income Term Fund NU9 Apr 25, 2025 18.60 +19.05   
 Nuvista Energy Ltd. NVG Apr 25, 2025 7.85 +3.29   
 NV Bekaert SA. BK8N Apr 25, 2025 33.50 +3.72   
 NV Gold 8NV0 Apr 25, 2025 0.06 -24.36   
 NVE Corporation NVK Apr 25, 2025 50.50 +3.48   
 NVIDIA CORP. CDR REG.S NVDG Apr 25, 2025 16.00 +8.47   
 NVIDIA Corporation NVD Apr 25, 2025 97.51 +9.66   
 NVR Inc. NVE Apr 25, 2025 6 250.00 +0.81   
 NWDS CHINA NWM Apr 25, 2025 0.02 0.00   
 NWF Group NYY Apr 25, 2025 2.00 -0.99   
 NWS HOLDINGS NWS Apr 25, 2025 0.79 +1.95   
 NX Filtration N.V. 9KJ Apr 25, 2025 3.43 +8.54   
 NXG NextGen Infrastructure Income Fund V3Z Apr 25, 2025 37.28 -0.25   
 NXP Semiconductors N.V. VNX Apr 25, 2025 170.00 +12.58   
 NYESA VALOS CO.EO 0,01 7NY0 Apr 25, 2025 0.00 0.00   
 Nyfosa 2JM Apr 25, 2025 8.21 +4.72   
 Nynomic AG M7U Apr 25, 2025 12.80 +1.19   
 Nyrstar NV 3NY1 Apr 25, 2025 0.05 +3.77   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.